Furuisen Biotechnology

Beijing Furuisen Biotechnology is a Chinese life sciences company that specializes in the development and production of cell culture media and high-quality animal sera. Established in 2013, the company provides critical raw materials and reagents for the biopharmaceutical industry, including fetal bovine serum (FBS) and specialized media for mammalian cell culture. Its products support a wide range of applications such as vaccine development, recombinant protein production, and cell therapy research. Furuisen is recognized as a significant domestic supplier in China's upstream bioprocessing sector, serving both academic research institutions and commercial biotechnology firms.